Table 2

Baseline and Echocardiographic Characteristics According to Presence of MSIMI

No MSIMI
(n = 127)
MSIMI
(n = 98)
p Value
Age, yrs63.5 ± 10.062.8 ± 10.00.5861
Race, white109 (85.8)80 (81.6)0.5045
Women17 (13.4)20 (20.4)0.2196
BMI, kg/m229.0 ±4.528.4 ±4.50.3256
Living arrangements, alone15 (11.8)19 (19.4)0.1658
Marital status, not married23 (18.1)27 (27.6)0.1267
Current smoker12 (9.4)16 (16.3)0.2302
Current medical therapy
 ASA121 (96.0)94 (96.9)1.0000
 Other antiplatelet agents50 (39.4)46 (47.4)0.2844
 ACE inhibitors79 (62.2)62 (63.9)0.9018
 ARBs15 (11.9)17 (17.5)0.3201
 Beta-blockers103 (81.1)82 (84.5)0.6215
 Calcium-channel blockers29 (23.0)20 (20.6)0.7906
 Statins113 (89.7)92 (95.8)0.1463
History of MI51 (40.2)47 (48.0)0.4844
History of CABG51 (40.2)43 (43.9)0.6711
History of PCI79 (62.2)64 (65.3)0.7342
History of DM38 (29.9)25 (25.5)0.7342
History of HTN102 (80.3)74 (75.5)0.4821
History of hyperlipidemia119 (93.7)91 (92.9)1.0000
NYHA functional class
 I115 (90.6)90 (91.8)
 II8 (6.3)7 (7.1)0.7053
 III4 (4.1)1 (1.0)
History of depression15 (11.8)13 (13.3)0.9013
Resting LVEF, %58.7 ± 8.257.8 ± 10.30.4817
Resting WMSI1.11 ± 0.281.19 ± 0.340.0725
Resting MV deceleration time, ms228.1 ± 58.2232.6 ± 60.00.5726
Resting E/A ratio0.97 ± 0.341.00 ± 0.300.4976
Resting E/e′11.7 ± 4.212.2 ± 4.70.4785
Resting eas index0.09 ± 0.030.11 ± 0.04<0.0001

Values are mean ± SD or n (%).

Abbreviations as in Table 1.